سعر ستاتوكاست 4مجم 10 اكياس 2024

Statukast 4 mg oral granules (Adwia, Egypt), 10 sachets: montelukast 4 mg per sachet, a leukotriene receptor antagonist for asthma and allergic rhinitis in young children.

• Prophylaxis and chronic treatment of asthma (from 12 months of age)Population: Paediatric, 12 months and olderDailyMed (U.S. National Library of Medicine)
• Relief of symptoms of seasonal (from 2 years) and perennial (from 6 months) allergic rhinitis when alternatives are inadequate or not toleratedPopulation: PaediatricDailyMed (U.S. National Library of Medicine)

• Most common in controlled trials (>=5% and more than placebo): upper respiratory infection, fever, headache, pharyngitis, cough, abdominal pain, diarrhoea, otitis media, influenza, rhinorrhoea, sinusitis, otitis.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to any of its components.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Boxed warning: serious neuropsychiatric events (agitation, aggression, depression, sleep disturbances, suicidal thoughts and behaviour including suicide) have been reported; weigh benefits and risks, and advise caregivers to watch for behaviour changes and stop the drug and contact a doctor if they occur.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Not indicated for reversal of bronchospasm in acute asthma attacks; rescue medication should be available.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Systemic eosinophilia, sometimes with features of vasculitis consistent with Churg-Strauss syndrome, has been reported, sometimes associated with reduction of oral corticosteroids.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Theophylline, prednisone, prednisolone, oral contraceptives, fexofenadine, digoxin, warfarin, gemfibrozil, itraconazole, thyroid hormones, CYP450 inducers and othersNo dose adjustment is needed when co-administered with these medicines.DailyMed (U.S. National Library of Medicine)

• Cohort studies over decades have not established a drug-associated risk of major birth defects; no adverse developmental effects in rats and rabbits at about 100-110 times the maximum recommended human dose.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Montelukast is present in human milk; available data do not suggest a significant risk of adverse reactions in breastfed infants.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Montelukast: Orally active, selective antagonist of the cysteinyl leukotriene type-1 (CysLT1) receptor, blocking LTD4-mediated airway oedema, smooth-muscle contraction and inflammation (SINGULAIR US label).